It looks like you're new here. If you want to get involved, click one of these buttons!
URL removed due to advertisements on siteFDA Approves Exalgo
The U.S. Food and Drug Administration (FDA) has approved Exalgo (hydromorphone HCl) Extended-Release Tablets, (CII).
The indication for Exalgo is once daily administration for the management of moderate to severe pain in opioid-tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time.